Page 2882 - Cote clinical veterinary advisor dogs and cats 4th
P. 2882
Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables. 1529
Endocarditis, 1221 English foxhound Eosinophilic bronchitis
aortic valve, subaortic stenosis and, 950 familial nephropathy in, 169 canine. See Eosinophilic bronchopneumopathy (EBP)
protein-losing nephropathy in, 830.e2
bacterial isolates in, 1202.e1
feline. See Feline asthma
VetBooks.ir bartonellosis and, 112 English pointer. See also Pointer Eosinophilic bronchopneumopathy (EBP), 298–299, 553
Eosinophilic enterocolitis, 543
footpad disorders in, 350
infective, 294–296
Eosinophilic granuloma complex, 300–301, 300f
mesenteric volvulus in, 649
vegetative, 294
Endochondral ossification, disturbed, 723
atopic dermatitis and, 92
Endocrine disorders sensory polyneuropathies in, 808 Eosinophilic granulomatosis, 299
stunted growth in, 946
collapse and, 193 English setter, eyelid masses in, 318 Eosinophilic keratoconjunctivitis, 568.e1–568.e2,
gastrointestinal, 383.e2–383.e3 English shepherd, MDR1 mutation in, 639 568.e1f
pododermatitis and, 799 English springer spaniel. See also Spaniel breeds; Springer Eosinophilic myositis, 637
stunted growth and, 947 spaniel Eosinophilic panosteitis, 750
Endogenous lipid pneumonia, 553 aggression in, 40 Eosinophilic pneumonia. See Eosinophilic
Endometritis, purulent. See Pyometra bronchiectasis in, 132 bronchopneumopathy (EBP)
Endomyocardial split of the left atrium. See Atrial rupture Eisenmenger’s syndrome in, 288.e2 Eosinophilic pneumonitis, heartworm disease and, 417
Endophthalmitis, 214 epilepsy in, 903 Eosinophilic ulcer. See Eosinophilic granuloma complex
Endoscopy eyelid masses in, 318 Epakitin. See Chitosan-based phosphate binder
balloon dilatation, for pyloric outflow obstruction, familial nephropathy in, 169 Ependymoma, 932
851.e3 footpad disorders in, 350 Ephedrine
bladder. See Cystoscopy immune-mediated hemolytic anemia in, 60 administration and dosage of, 1476
bronchial. See Bronchoscopy pannus in, 748 in herbal remedies, 463t–464t
colonoscopy, preparation for, 1099 phosphofructokinase deficiency in, 59 toxicosis from, 240–241
cystoscopy, 1085–1086, 1086.e1f pseudohyperkalemia in, 495 EPI. See Exocrine pancreatic insufficiency
esophageal. See Esophagoscopy retinal detachment in, 885 Epidermal collarettes, 852f
frontal sinus, 919f sebaceous adenitis in, 901 Epidural analgesia/anesthesia, 1100.e2–1100.e4,
in gastric ulcer, 381 ventricular septal defect in, 1036 1100.e3f, 1129–1130
joint. See Arthroscopy Enophthalmos, orbital disease and, 716 Epilepsy, idiopathic, 301–303. See also Seizures
nasal cavity. See Rhinoscopy Enostosis (panosteitis), 750 Epinephrine
in protein-losing enteropathy, 601 Enoxaparin, 1476 administration and dosage of, 1476
thoracic, 1166.e1 Enoz, 661.e2 for anaphylaxis, 55
upper gastrointestinal, 1098–1099 Enrofloxacin for hypotension, 523.e4
urinary bladder. See Cystoscopy administration and dosage of, 1476 Epiphora, 703–704, 1249.e1
vaginal. See Vaginoscopy for antibiotic-responsive diarrhea, 261 Episcleral hyperemia/injection. See Red eye
Endotoxemia for bacterial cystitis, 234 Episcleritis, 304–305, 304.e1f
description of, 1369 for bartonellosis, 113 Episclerokeratitis, 304
salmonellosis and, 899 for bile duct obstruction, 118 Epistaxis, 305–306, 678, 1221
Endotracheal intubation, 1123.e8–1123.e9, 1123.e9f for Campylobacter enteritis, 143.e4 Epithelioma. See Cutaneous neoplasia
Endotracheal tube overinflation, and tracheal rupture, drug interactions, 1510.e1t–1510.e5t Epitheliotropic lymphoma, 215.e1f, 216, 350,
986 for gallbladder rupture, 376 604.e5–604.e6, 714. See also Cutaneous lymphoma
Enema for granulomatous enteritis/colitis, 396 EPO. See Erythropoietin (EPO)
barium, 1062.e1, 1062.e1f for hemotropic mycoplasmosis, 439 Epoetin. See Erythropoietin (EPO)
for constipation/obstipation, 203 for hepatobiliary infections and abscesses, Epogen. See Erythropoietin (EPO)
evacuation/retention, 1099–1100, 1100f, 1100.e1f 456 Eprinomectin, 1510.e6t
phosphate, 1099 for infective endocarditis, 295 Epsiprantel, for echinococcosis, 281.e1
toxicosis from, 788.e2–788.e3 for Mycoplasma infections, 671.e2 Epsom salt, 800
Engine cleaners/degreasers, 782 for necrotizing fasciitis, 685 Epulides, 306–309, 307f–308f
English bulldog. See also Bulldog for Rocky Mountain spotted fever, 892 Epulis, 711–713
acne in, 15 for salmonellosis, 899 Equipment malfunction, anesthesia, 65
ascites in, 2.e4f for septic peritonitis, 779.e3, 780 Erection, persistent. See Priapism
brachycephalic airway syndrome in, 128 for tracheal avulsion, 987 ERG. See Electroretinogram (ERG)
cerebellar cortical degeneration in, 149.e3 for tularemia, 1000 Ergocalciferol, 164, 520, 1476
ectopic ureter in, 282 for Ureaplasma infections, 671.e2 Erosive skin disorders. See Ulcerative and erosive skin
Eisenmenger’s syndrome in, 288.e2 Entamoeba histolytica, 830.e6 disorders
entropion in, 296 Enteral nutrition. See Nutritional support Erysipelothrix, 295
fecal incontinence in, 537 Enteritis. See also Enterocolitis; Gastroenteritis Erythema multiforme, 309.e2–309.e3
heart base tumor in, 407 acute, nonspecific, 382–383 Erythrocyte(s). See Red blood cells
hemivertebrae in, 933.e2 Campylobacter spp. and, 143.e3–143.e4 Erythrocyte aplasia. See Nonregenerative anemia
keratoconjunctivitis sicca in, 569 coronaviral, 217.e2–217.e3 Erythrocyte refractile body. See Heinz bodies
lymphedema in, 602.e2 feline infectious. See Feline panleukopenia Erythrocytosis, 1222, 1336–1337. See also Polycythemia
mitral valve dysplasia in, 657 granulomatous, 395–396, 396.e1f, 543 paraneoplastic syndromes and, 754
nephrolithiasis in, 689 parvoviral. See Canine parvoviral enteritis primary. See Polycythemia vera
pigmentary abnormalities in, 195 protozoal, 830.e6. See also specific protozoal parasites Erythroderma, 227
pulmonic stenosis in, 844 Enterobacter, infective endocarditis and, 295 Erythroleukemia, 1432a
pyoderma in, 851 Enterocolitis. See also Colitis; Enteritis Erythromycin
recurrent flank alopecia in, 47, 869 bacteria that cause, 1202.e1 administration and dosage of, 1476
sacrocaudal dysgenesis in, 933.e2 clostridial, 182–183 adverse effects of, 1510.e6t
spina bifida in, 933.e2 salmonellosis and, 899 for bilious vomiting syndrome, 120
stunted growth in, 946 Enterogastric lavage, 946.e2 for Campylobacter enteritis, 143.e4
tetralogy of Fallot in, 965 Enteropathies, 1221.e1t for Mycoplasma infections, 620
third eyelid gland prolapse in, 970 Enterotoxigenic bacteria, in adulterated diets, for nocardiosis, 20–21
tremors in, 661 37t for Ureaplasma infections, 620
tremors/myoclonus in, 994 Enterotoxin, Clostridium perfringens and, 182 Erythropoietic protoporphyria, 174
trichiasis in, 273 Enthesophyte, 13f Erythropoietin (EPO)
urethral prolapse in, 1011.e2 Entocort. See Budesonide administration and dosage of, 1476
urolithiasis in, 1014.e2, 1019 Entropion, 296–298, 296.e2f for anemia of chronic kidney disease, 170
ventricular septal defect in, 1036 Enucleation for myelodysplasia, 672–673
English cocker spaniel. See also Cocker spaniel; Spaniel for globe proptosis, 823–824 serum levels of, 1337
breeds for intraocular neoplasia, 561 Eschar, 138–139
aggression in, 40 for ocular size abnormalities, 705 Escherichia coli
anal sac adenocarcinoma in, 29 Envenomation abortion and, 2
chronic hepatitis in, 450–452 snakebite, 921–923, 922f, 1450.e1a in adulterated diets, 37t
dilated cardiomyopathy in, 263 spider, 928–929 discospondylitis and, 266, 267t
nephrotic syndrome in, 691 Environmental enrichment, 332 infective endocarditis and, 295
protein-losing nephropathy in, 830.e2 Envoplakin, 756.e3 multidrug resistant, in bacterial cystitis, 234
stunted growth in, 946 Eosinophil(s), 1336 O157:H7, 431.e2
trichiasis in, 273 Eosinophilia, 1221 and pneumonia, 795
www.ExpertConsult.com